Pharmaceutical

Purdue and Sackler family agree to $7.4bn national opioid settlement

The settlement ends the Sackler family’s ownership of the Oxycontin developer Purdue Pharma.

Jan 26, 2025 - 06:00
Purdue and Sackler family agree to $7.4bn national opioid settlement
The settlement ends the Sackler family’s ownership of the Oxycontin developer Purdue Pharma.
Read the original article

Tags:

Previous Article

Ascentage Pharma raises $126m in first biotech IPO of 2025

Next Article

FDA approves drug application for Lupin’s heart failure therapy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Large insurers say up to one-quarter of claims run through Change Healthcare

STAT+: Large insurers say up to one-quarter of claims r...

Mar 6, 2024

Abortion funds run short of money as demand soars and donations fall

Abortion funds run short of money as demand soars and d...

Jan 24, 2024

STAT+: Medical leaders decry Supreme Court decision on affirmative action

STAT+: Medical leaders decry Supreme Court decision on ...

Jul 2, 2023